Department of Pharmacy, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy.
Eur J Pharm Sci. 2012 Aug 15;46(5):475-83. doi: 10.1016/j.ejps.2012.03.013. Epub 2012 Mar 30.
Trans-scleral delivery is nowadays considered as a possible way to deliver drugs to the posterior segment of the eye. Despite the potentiality of this administration route, there is a lack of fundamental knowledge on the role of the numerous barriers involved. The aim of this work was to develop an easy and cheap ex vivo method to evaluate the barrier properties of the choroid-Bruch's layer and in particular to estimate the role of melanin in drug diffusion through ocular tissues. In vitro binding studies were performed to estimate drug affinity for melanin; model molecules used were methylene blue, propranolol, levofloxacin and methylprednisolone sodium succinate. The ex vivo model set up is based on porcine eye bulbs with light blue iris or brown iris. While the choroid of brown eyes is dark, the choroid of blue eyes is transparent, due to the absence of melanin. Permeation experiments using pigmented and not-pigmented porcine tissues gave the opportunity to discriminate between the barrier role of choroid-Bruch's membrane as such and the barrier role of melanin. Ex vivo permeation experiments can be performed using isolated choroid-Bruch's or the sclera-choroid-Bruch's layer. In this last case, it is possible to take into account also the barrier role of the sclera that tends to decrease the drug concentration at the sclera/choroid interface, thus amplifying the effect of melanin. The data obtained in this paper indicate that for some drugs melanin can really represent a barrier and the effect can imply a lower drug flux or simply a longer lag time depending on the kind of drug and the concentration applied. However, it is a saturable barrier, thus its effect can probably be overtaken by high doses or multiple administrations. The ex vivo model set up can help to refine computational models, to better evaluate the interplay among static, dynamic and metabolic barriers. Additionally, since human eyes display a full range of pigmentation, the model could also be useful to investigate the possible influence of pigmentation phenotype on trans-scleral delivery.
经巩膜递药法目前被认为是一种向眼后段递药的可行方法。尽管该给药途径具有很大的潜力,但人们对涉及的众多屏障的基本特性知之甚少。本工作旨在建立一种简便、廉价的评估脉络膜-布鲁赫膜屏障特性的离体方法,特别是评估黑色素在药物经眼部组织扩散中的作用。进行了体外结合研究以评估药物与黑色素的亲和力;使用的模型分子为亚甲蓝、普萘洛尔、左氧氟沙星和甲泼尼龙琥珀酸钠。离体模型基于具有浅蓝色虹膜或棕色虹膜的猪眼球建立。由于棕色眼睛的脉络膜中没有黑色素,因此是黑色的,而蓝色眼睛的脉络膜是透明的。使用有色和无色猪组织进行渗透实验,有机会区分脉络膜-布鲁赫膜本身的屏障作用和黑色素的屏障作用。离体渗透实验可以使用分离的脉络膜-布鲁赫膜或巩膜-脉络膜-布鲁赫膜层进行。在后一种情况下,还可以考虑巩膜的屏障作用,巩膜会降低巩膜/脉络膜界面处的药物浓度,从而放大黑色素的作用。本文获得的数据表明,对于某些药物,黑色素确实可以构成屏障,其作用可能表现为药物通量较低或仅仅是滞后时间较长,这取决于药物种类和施加的浓度。然而,这是一种可饱和的屏障,因此其作用可能会被高剂量或多次给药所超越。所建立的离体模型有助于完善计算模型,更好地评估静态、动态和代谢屏障之间的相互作用。此外,由于人类眼睛表现出各种程度的色素沉着,该模型还可以用于研究色素沉着表型对经巩膜递药的可能影响。